艾滋病毒治疗后控制器中的功能性抗体格局是异质的
Nicholas E Webb1, Matthew J Gorman1, Lily J Parker1
1Ragon Institute of Mass General MIT and Harvard, Cambridge, Massachusetts, USA.
Journal of virology
|November 28, 2025
概括
一个罕见的艾滋病毒感染者群,称为治疗后控制者 (PTC),在停止抗逆转录病毒疗法 (ART) 后可以保持缓解. 这项研究发现,虽然抗体反应在病毒反弹期间有动态变化,但它们不能预测谁会成为PTC.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 艾滋病毒研究 艾滋病毒研究
背景情况:
- 艾滋病毒-1 建立了一个潜在的储存库,尽管抗逆转录病毒疗法 (ART) 仍然存在.
- 治疗后控制器 (PTC) 在ART停止后保持持久的HIV缓解,为病毒控制提供了洞察力.
- 幽默免疫的作用,特别是Fc介导的抗体功能,在治疗后的控制中,尚未完全理解.
研究的目的:
- 研究幽默免疫反应,特别是Fc介导的抗体功能对PTCs病毒反弹动态的影响.
- 在ART中断后,比较PTC和非控制者 (NC) 之间的抗体特征和Fc-effector功能.
主要方法:
- 使用综合系统血清学方法来分析Env特异性抗体特征和Fc-effector功能.
- 评估了抗体依赖的细胞化,中性粒细胞化,补体沉积和NK细胞激活.
- 在PTC中长度分析了抗体反应,并在ART停止后的病毒反弹期间匹配了NC.
主要成果:
- 在ART中断之前的基线抗体特征没有区分PTC和NC.
- 在病毒反弹期间,抗体反应以动态和高度个性化的方式演变.
- 在反弹期间观察到Fc功能抗体特征的明显的个体特异性转变,表明免疫系统的适应.
结论:
- 幽默性免疫反应在病毒反弹期间动态适应,而不是由静态基线特征决定.
- 纵向免疫分析对于理解与治疗后控制相关的幽默免疫的演变至关重要.
- 虽然Fc介导的抗体功能具有适应性,但它们可能不是PTC中持续性HIV缓解的主要驱动因素.
更多相关视频
07:10Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
Published on: September 14, 2014
14.6K
14:23A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
16.1K
相关概念视频
Retrovirus Life Cycles
49.2K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.2K
Diversity of Antigen Receptors
1.3K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.3K
